سرطان الأقنية الصفراوية النقيري

الأقسام والتخصصات

تضم Mayo Clinic أكبر العيادات وأكثرها خبرة في الولايات المتحدة الأمريكية، وتوجد فروعها في ولاية أريزونا وفلوريدا ومينيسوتا. ويتعاون كادرها الماهر المكون من عدة تخصصات لضمان تقديم علاج ناجح ورعاية عالية الجودة.

الأبحاث

Researchers at Mayo Clinic are studying new ways to diagnose and treat hilar cholangiocarcinoma. This research is conducted as part of the Division of Gastroenterology and Hepatology in coordination with Mayo Clinic Cancer Center.

Mayo Clinic Cancer Center receives funding from the National Cancer Institute (NCI) and is an NCI-designated comprehensive cancer center — recognition for an institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.

Areas of research include:

• Studying the association of aspirin and statin medicines with a reduced risk of cholangiocarcinoma.
• Investigating the molecular genetics of tumors and identifying biomarkers, which may aid in early diagnosis or lead to new targeted therapies.
• Doing clinical trials for new targeted therapies. These trials are possible because of Mayo Clinic's high patient volume for primary sclerosing cholangitis and bile duct cancer.
• Expanding surgical options and refining techniques, including vessel and bile duct reconstruction, to widen the number of people who may qualify for curative approaches.
• Proving that the biomarker CA 19-9 is useful for staging cholangiocarcinoma and understanding the prognosis for people with the disease.

Publications

See a list of publications about cholangiocarcinoma by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.